1,3-Dioxolane, 2-(5-bromo-2,4-difluorophenyl)-, 98%, 5g

3-Bromo-7-chloropyrazolo[1,5-a]pyrimidine, 97.0%, 250mg

7-Bromo-2-methylquinazolin-4(3H)-one, 95.0%, 5g

1-(3-Fluoro-(5-methylsulfanyl)phenyl)pyrolidine, 98%, 1g

8-Bromo-4-chloro-2-methylquinoline, 95.0%, 1g

4-(4-Biphenylyl)butyric acid, 95.0%, 250mg

1-N-Cbz-3-Piperidone, 97.0%, 100g

Antimony powder, min. 99.5%, <100 mesh, 250 g, plastic packaging.

4-Fluoro-2-(trifluoromethyl)cinnamic acid, 1g

5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; but-2-enedioic acid, 97.0%, 10g

2-Fluoro-4-(trans-4-pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)biphenyl>98.0%(GC)1g

Tricaprin>98.0%(GC)10g

Palladium on SH Silica Gel (0.1mmol/g)1g